Cerevel Enterprise Value Multiple from 2010 to 2024

CERE Stock  USD 42.29  0.09  0.21%   
Cerevel Therapeutics' Enterprise Value Multiple is decreasing over the years with stable fluctuation. Enterprise Value Multiple is expected to dwindle to -15.12. During the period from 2010 to 2024 Cerevel Therapeutics Enterprise Value Multiple annual values regression line had coefficient of variation of (77.52) and r-squared of  0.05. View All Fundamentals
 
Enterprise Value Multiple  
First Reported
2010-12-31
Previous Quarter
(14.40)
Current Value
(15.12)
Quarterly Volatility
15.25132151
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Cerevel Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cerevel main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.1 M, Interest Expense of 12.6 M or Selling General Administrative of 118.3 M, as well as many exotic indicators such as Price To Sales Ratio of 39.33, Dividend Yield of 0.0 or Price Book Value Ratio of 9.22. Cerevel financial statements analysis is a perfect complement when working with Cerevel Therapeutics Valuation or Volatility modules.
  
This module can also supplement Cerevel Therapeutics' financial leverage analysis and stock options assessment as well as various Cerevel Therapeutics Technical models . Check out the analysis of Cerevel Therapeutics Correlation against competitors.

Latest Cerevel Therapeutics' Enterprise Value Multiple Growth Pattern

Below is the plot of the Enterprise Value Multiple of Cerevel Therapeutics Holdings over the last few years. It is Cerevel Therapeutics' Enterprise Value Multiple historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cerevel Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Enterprise Value Multiple10 Years Trend
Pretty Stable
   Enterprise Value Multiple   
       Timeline  

Cerevel Enterprise Value Multiple Regression Statistics

Arithmetic Mean(19.67)
Coefficient Of Variation(77.52)
Mean Deviation13.33
Median(14.40)
Standard Deviation15.25
Sample Variance232.60
Range34.4162
R-Value(0.23)
Mean Square Error237.81
R-Squared0.05
Significance0.42
Slope(0.77)
Total Sum of Squares3,256

Cerevel Enterprise Value Multiple History

2024 -15.12
2023 -14.4
2022 -13.6
2021 -19.41
2020 -5.84
2015 -39.67
2014 -6.03

About Cerevel Therapeutics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Cerevel Therapeutics income statement, its balance sheet, and the statement of cash flows. Cerevel Therapeutics investors use historical funamental indicators, such as Cerevel Therapeutics's Enterprise Value Multiple, to determine how well the company is positioned to perform in the future. Although Cerevel Therapeutics investors may use each financial statement separately, they are all related. The changes in Cerevel Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cerevel Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Cerevel Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Cerevel Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Enterprise Value Multiple(14.40)(15.12)
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cerevel Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cerevel Therapeutics' short interest history, or implied volatility extrapolated from Cerevel Therapeutics options trading.

Pair Trading with Cerevel Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cerevel Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cerevel Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving against Cerevel Stock

  0.42MGNX MacroGenics Financial Report 14th of May 2024 PairCorr
The ability to find closely correlated positions to Cerevel Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cerevel Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cerevel Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cerevel Therapeutics Holdings to buy it.
The correlation of Cerevel Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cerevel Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cerevel Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cerevel Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Cerevel Therapeutics is a strong investment it is important to analyze Cerevel Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cerevel Therapeutics' future performance. For an informed investment choice regarding Cerevel Stock, refer to the following important reports:
Check out the analysis of Cerevel Therapeutics Correlation against competitors.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Complementary Tools for Cerevel Stock analysis

When running Cerevel Therapeutics' price analysis, check to measure Cerevel Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cerevel Therapeutics is operating at the current time. Most of Cerevel Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cerevel Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cerevel Therapeutics' price. Additionally, you may evaluate how the addition of Cerevel Therapeutics to your portfolios can decrease your overall portfolio volatility.
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Equity Valuation
Check real value of public entities based on technical and fundamental data
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Is Cerevel Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cerevel Therapeutics. If investors know Cerevel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cerevel Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.67)
Return On Assets
(0.25)
Return On Equity
(0.72)
The market value of Cerevel Therapeutics is measured differently than its book value, which is the value of Cerevel that is recorded on the company's balance sheet. Investors also form their own opinion of Cerevel Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Cerevel Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cerevel Therapeutics' market value can be influenced by many factors that don't directly affect Cerevel Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cerevel Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cerevel Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cerevel Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.